Acute inflammation is the body’s natural response to injury, initiating the healing process through immune cell activity. However, this response can unfortunately become chronic, as is seen in conditions such as rheumatoid arthritis, lupus, and allergies. Chronic inflammation occurs when immune cells continue to respond unchecked even after the original injury has healed, resulting in persistent inflammatory conditions. Addressing these challenges through innovative drug discovery research is crucial to developing effective therapeutics that can modulate the inflammatory response and restore health.
Benefits of Choosing Eurofins Discovery for Inflammation Research
At Eurofins Discovery, our team of experts boasts extensive knowledge and experience in inflammation research with a successful track record of advancing multiple clinical candidates, leveraging our comprehensive expertise from in vitro to in vivo. Our translational approach spans from target-based biochemical and cellular assays to disease-relevant primary cellular systems. We specialize in:
- Identifying key target modulation biomarkers
- Establishing clear PK/PD relationships through biomarker measurement
- Demonstrating efficacy in our in vivo pharmacology models
- Flexible pricing models, both Fee-for-Service (FFS) and Full Time Equivalent (FTE) solutions available
Partnering with us ensures expert guidance and flexibility throughout your inflammatory disease program, facilitating rapid and efficient project progression.
Contact Us to Move Your Inflammation Research Forward
With our innovative solutions and deep understanding of inflammatory diseases, Eurofins Discovery is your ideal partner for inflammation drug discovery. Contact us today to learn how we can help you achieve your research goals and expedite the discovery of effective therapeutics.
